Drug Profile
Research programme: focal adhesion kinase inhibitors - Pfizer
Alternative Names: CP-941222; PF-573228; PF-941222Latest Information Update: 04 Aug 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Focal adhesion protein-tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 Aug 2009 Discontinued - Preclinical for Cancer in USA (PO)
- 12 Nov 2008 This programme is still in active development
- 01 May 2006 Preclinical trials in Cancer in USA (PO)